# Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation

**Authors:** Ranodeep Chatterjee, Aditya Shukla, Kausiki Chakrabarti, Urmi Chatterji

PMC · DOI: 10.3389/fonc.2024.1393626 · Frontiers in Oncology · 2024-03-14

## Full-text entities

- **Genes:** CLEC12A (C-type lectin domain family 12 member A) [NCBI Gene 160364] {aka CD371, CLL-1, CLL1, DCAL-2, MICL, hKLRL1}
- **Diseases:** inflammation (MESH:D007249), cancer (MESH:D009369), breast cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10974658/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10974658/full.md

---
Source: https://tomesphere.com/paper/PMC10974658